Photodynamic therapy for the treatment of barrett's esophagus: a systematic review and economic evaluation
Health Technology & Policy Unit
Record ID 32013000163
English
Authors' recommendations:
Compared to esophagectomy, PDT therapy is less costly and is associated with fewer major adverse events. Photodynamic therapy appears to be slightly more expensive than most of the other endoscopic therapies for Barrett's esophagus, but the difference in costs between the endoscopic therapies is relatively inconsequential. Of all the endoscopic therapies, radiofrequency ablation (RFA) appears to offer the best value for money, but evidence on long term outcomes (in particular, rates of Barrett's recurrence and progression to cancer) with RFA and other endoscopic therapies is lacking.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.health.alberta.ca/documents/AHTDP-PDT-BE-UofA-STE.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
MeSH Terms
- Barrett Esophagus
- Photosensitizing Agents
Contact
Organisation Name:
Health Technology and Policy Unit
Copyright:
Health Technology & Policy Unit (HTPU)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.